Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IK-01 confirmatory study in knee osteoarthritis
jRCT2053240275Active, not recruiting
- Sponsor
- CynosBio
- Start
- Feb 2025
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Open-label trial of CaReS and hyaluronic acid in knee osteoarthritis (OA) (2 arms), sponsored by CynosBio. Primary endpoint: Change from baseline in WOMAC total score. Started Feb 2025; status: active, not recruiting.
02
Drugs
CaReShyaluronic acid
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on jRCT2053240275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2053240275.